SEI Investments’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
Other funds holding DSGN
DTC
BBA
SEI Investments's DSGN Position: Q3 2026 in Review
SEI Investments increased its Design Therapeutics (DSGN) stake by 48% in Q3 2026, buying an estimated $150K and bringing the position to 33,603 shares worth $422K. The position accounts for ﹤0.01% of the portfolio, ranked #2716.
SEI Investments first reported a position in DSGN in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.42M in Q1 2026. 142 funds tracked by Wall St. Rank hold DSGN as of Q3 2026.
- SEI Investments held 33,603 shares of Design Therapeutics worth $422K as of Q3 2026.
- SEI Investments bought 10,863 Design Therapeutics shares in Q3 2026, an estimated $150K.
- Design Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q3 2026, its #2716 holding.
- SEI Investments first reported a position in Design Therapeutics in Q4 2025 and has held it in 4 quarters since.
- SEI Investments's Design Therapeutics position peaked at $1.42M in Q1 2026.
- 142 funds tracked by Wall St. Rank held Design Therapeutics as of Q3 2026.
Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.